KRAS and cancer: These PSCs can be activated by PDAC cell-derived KRAS (G12D) signaling, which regulates cancer cell proliferation and apoptosis, increases mitochondrial capacity via the IGF1R/AXL-AKT axis, and modifies metabolism138.